Oluwafemi Adeleke Ojo

Prof. Oluwafemi Adeleke Ojo

Department of Biochemistry, Bowen University, Iwo, Osun, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Gaber El-Saber BatihaGaber El-Saber Batiha
Gaber El-Saber Batiha
AAAli Alqahtani
Ali Alqahtani
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
Hazem ShaheenHazem Shaheen
Hazem Shaheen
LWLamiaa Wasef
Lamiaa Wasef
Helal HettaHelal Hetta
Helal Hetta
Pepper originated from the Capsicum genus, which is recognized as one of the most predominant and globally distributed genera of the Solanaceae family. It is a diverse genus, consisting of more than 31 different species including five domesticated species, Capsicum baccatum, C. annuum, C. pubescen, C. frutescens, and C. chinense. Pepper is the most widely used spice in the world and is highly valued due to its pungency and unique flavor. Pepper is a good source of provitamin A; vitamins E and C; carotenoids; and phenolic compounds such as capsaicinoids, luteolin, and quercetin. All of these compounds are associated with their antioxidant as well as other biological activities. Interestingly, Capsicum fruits have been used as food additives in the treatment of toothache, parasitic infections, coughs, wound healing, sore throat, and rheumatism. Moreover, it possesses antimicrobial, antiseptic, anticancer, counterirritant, appetite stimulator, antioxidant, and immunomodulator activities. Capsaicin and Capsicum creams are accessible in numerous ways and have been utilized in HIV-linked neuropathy and intractable pain.

6 August 2022 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
TETobiloba C. Elebiyo
Tobiloba C. Elebiyo
DRDamilare Rotimi
Damilare Rotimi
IEIkponmwosa O. Evbuomwan
Ikponmwosa O. Evbuomwan
RMRotdelmwa Filibus Maimako
Rotdelmwa Filibus Maimako
MIMatthew Iyobhebhe
Matthew Iyobhebhe
OAOluyomi Stephen Adeyemi
Oluyomi Stephen Adeyemi
Vascularization is fundamental to the growth and spread of tumor cells to distant sites. As a consequence, angiogenesis, the sprouting of new blood vessels from existing ones, is a characteristic trait of cancer. In 1971, Judah Folkman postulated that tumour growth is angiogenesis dependent and that by cutting off blood supply, a neoplastic lesion could be potentially starved into remission. Decades of research have been devoted to understanding the role that vascular endothelial growth factor (VEGF) plays in tumor angiogenesis, and it has been identified as a significant pro-angiogenic factor that is frequently overexpressed within a tumor mass. Today, anti-VEGF drugs such as Sunitinib, Sorafenib, Axitinib, Tanibirumab, and Ramucirumab have been approved for the treatment of advanced and metastatic cancers. However, anti-angiogenic therapy has turned out to be more complex than originally thought. The failure of this therapeutic option calls for a reevaluation of VEGF as the major target in anti-angiogenic cancer therapy. The call for reassessment is based on two rationales: first, tumour blood vessels are abnormal, disorganized, and leaky; this not only prevents optimal drug delivery but it also promotes hypoxia and metastasis; secondly, tumour growth or regrowth might be blood vessel dependent and not angiogenesis dependent as tumour cells can acquire blood vessels via non-angiogenic mechanisms. Therefore, a critical assessment of VEGF, VEGFRs, and their inhibitors could glean newer options such as repurposing anti-VEGF drugs as vascular normalizing agents to enhance drug delivery of immune checkpoint inhibitors.

22 April 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
TATemiloluwa Rhoda Adeyemo
Temiloluwa Rhoda Adeyemo
DRDamilare Rotimi
Damilare Rotimi
GBGaber El-Saber Batiha
Gaber El-Saber Batiha
GMGomaa Mostafa-Hedeab
Gomaa Mostafa-Hedeab
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
Colorectal cancer (CRC) is one of the most common and reoccurring diseases, as well as the world’s second largest cause of mortality. Despite existing preventative, diagnostic, and treatment methods, such as chemotherapy, the number of instances rises year after year. As a result, new effective medications targeting specific checkpoints should be developed to combat CRC. Natural compounds, such as curcumin, have shown significant anti-colorectal cancer characteristics among medications that can be used to treat CRC. These chemicals are phenolic compounds that belong to the curcuminoids category. Curcumin exerts its anti-proliferative properties against CRC cell lines in vitro and in vivo via a variety of mechanisms, including the suppression of intrinsic and extrinsic apoptotic signaling pathways, the stoppage of the cell cycle, and the activation of autophagy. Curcumin also has anti-angiogenesis properties. Thus, this review is aimed at emphasizing the biological effect and mode of action of curcumin on CRC. Furthermore, the critical role of these substances in CRC chemoprevention was emphasized.

17 June 2023 in Medicine in Novel Technology and Devices
Verified
Journal Article
Open access
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
HIHannah Sokolayam Ibrahim
Hannah Sokolayam Ibrahim
DRDamilare Emmanuel Rotimi
Damilare Emmanuel Rotimi
AOAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
AOAdebola Busola Ojo
Adebola Busola Ojo

21 February 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
JAJennifer Chidubem Amanze
Jennifer Chidubem Amanze
AOAbosede Itunuoluwa Oni
Abosede Itunuoluwa Oni
SGSusan Grant
Susan Grant
MIMatthew Iyobhebhe
Matthew Iyobhebhe
AOAdebola Busola Ojo
Adebola Busola Ojo
The treatment of diabetes involves the use of herbal plants, attracting interest in their cost-effectiveness and efficacy. An aqueous extract of Persea americana seeds (AEPAS) was explored in this study as a possible therapeutic agent in rats with diabetes mellitus. The induction of diabetes in the rats was achieved by injecting 65 mg/kg body weight (BWt) of alloxan along with 5% glucose. This study was conducted using thirty-six (36) male Wistar rats. The animals were divided into 6 equal groups, (n = 6) and treated for 14 days. In vitro assays for total flavonoid, phenols, FRAP, DPPH, NO, α-amylase, and α-glucosidase, were performed. Biochemical indices fasting blood sugar (FBS), BWt, serum insulin, liver hexokinase, G6P, FBP, liver glycogen, IL-6, TNF-α, and NF-ĸB in the serum, were investigated as well as the mRNA expressions of PCNA, Bcl2, PI3K/Akt in the liver and pancreas. The in vitro analyses showed the potency of AEPAS against free radicals and its enzyme inhibitory potential as compared with the positive controls. AEPAS showed a marked decrease in alloxan-induced increases in FBG, TG, LDL-c, G6P, F-1, 6-BP, MDA, IL-6, TNF-α, and NF-ĸB and increased alloxan-induced decreases in liver glycogen, hexokinase, and HDL-c. The diabetic control group exhibited pancreatic dysfunction as evidenced by a reduction in serum insulin, HOMA-β, expressions of PI3K/AKT, Bcl-2, and PCNA combined with an elevation in HOMA-IR. The HPLC revealed luteolin and myricetin to be the phytochemicals that were present in the highest concentration in AEPAS. The outcome of this research showed that the administration of AEPAS can promote the activation of the PI3K/AkT pathway and the inhibition of β-cell death, which may be the primary mechanism by which AEPAS promotes insulin sensitivity and regulates glycolipid metabolism.

13 April 2023 in Toxicology Reports
Verified
Journal Article
Open access
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
PNPearl Ifunanya Nwafor-Ezeh
Pearl Ifunanya Nwafor-Ezeh
DRDamilare Emmanuel Rotimi
Damilare Emmanuel Rotimi
MIMatthew Iyobhebhe
Matthew Iyobhebhe
AOAkingbolabo Daniel Ogunlakin
Akingbolabo Daniel Ogunlakin
AOAdebola Busola Ojo
Adebola Busola Ojo
Infertility has been a major issue in our society for many years, and millions of couples all over the world are still experiencing it. There are several reasons for and causes of infertility in both men and women. Recent studies have shown that apoptosis, inflammation, and oxidative stress contribute immensely to infertility. The data regarding this report were obtained through a thorough review of scientific articles published in various databases, including Elsevier, Web of Science, PubMed, Scopus, and Google Scholar. Furthermore, PhD and MSc theses were also reviewed when compiling the data. Apoptosis, also known as "programmed cell death," is a natural and harmless process that occurs in human beings. Although it can become harmful if altered, Inflammation, on the other hand, is the body’s reaction to detrimental stimuli caused by toxic substances or compounds, while oxidative stress is a phenomenon that results in an imbalance between the generation and aggregation of reactive oxygen species (ROS) in the cells against antioxidants. These three factors interchangeably bring about several reproductive disorders in the body, resulting in infertility. This review aims at discussing how apoptosis, inflammation, and oxidative stress play a role in human infertility. The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.